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Objective: The histopathologic hanges of fresh rat aortic valve allografls 
over time and the effect of cryopreservation were examined. Methods: 
Fifty-six syngeneic and allogeneic rat aortic valves were transplanted, 
either fresh or after cryopreservation, and then at different time points they 
were explanted and histologically examined in a blinded fashion. Results: 
Histopathologic hanges in the first week are similar in syngeneic and 
allogeneic grafts. Fresh syngeneic grafts and leaflets retained normal 
structure up to 56 days. Allogeneic grafts showed retrovalvular thrombus 
formation with leaflet ghosts and neointimal proliferation. Cryopreserva- 
tion did not alter this process. Conclusions: Cardiac allograft valves in the 
rat model undergo changes that are characteristic of cell-mediated rejec- 
tion and lead to valve failure. (J Thorac Cardiovasc Surg 1997;114:891-902) 
~ number of studies have demonstrated the supe- 
Lriority of cryopreserved aortic valve allografts 
compared with other bioprosthetic valves over long- 
term follow-up in regard to durability and low 
incidence of valve-related complicationsJ -4 Despite 
their advantages, however, aortic valve allografts do 
ultimately fail in the aortic position, the effective life 
of the average aortic homograft in an adult being 
about 15 years, s In children valve failure occurs 
faster for reasons that remain unknown. 6-8 The 
cause of homograft failure in children and adults is 
most likely multifactorial and includes mechanical, 
immunologic, and other factors. In particular, the 
role of immune-mediated rejection in the failure of 
allograft heart valves in human beings is uncertain. 
Although there is clear evidence of a donor-specific 
systemic immune response to allograft aortic valve 
implants in human beings and rats, the effects of 
such a response are unclear. TM Short retrieval to 
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cryopreservation times that would be expected to 
maximize viability and therefore antigenicity have 
been associated with increased failure of allograft 
valves in children. 12 The use of heart valve trans- 
plants between syngeneic and allogeneic strains of 
rats permits investigations into the role of immune- 
mediated rejection of these grafts. Evidence sug- 
gesting an immunologic basis has been presented by 
numerous authors. 12-16 This study describes the 
pathologic hanges in rats, over time, after trans- 
plantation of syngeneic versus allogeneic and fresh 
versus cryopresetved valves and identifies changes 
indicative of rejection. These changes could be in 
the form of either an acute or chronic rejection 
process. Acute rejection is microscopically charac- 
terized by a lymphocytic nfiltrate. Chronic rejection 
has been described in human and animal solid organ 
transplants and in the rat aortic allograft model and 
includes persistent perivascular inflammation, gen- 
eralized concentric intimal thickening, and medial 
necrosis.17, 18 An in-depth examination of the patho- 
logic changes and mechanisms underlying valve 
failure may help to define the relative role, time 
sequence, and magnitude of the main components 
of an immunologic reaction. This would have impor- 
tant implications for the choice and timing of ther- 
apeutic interventions aimed at modifying this re- 
sponse. 
Materials and methods 
Animals. Lewis and Brown Norway rats (Harlan 
Sprague Dawley, Inc., Indianapolis, Ind.) weighing 225 to 
300 gm were used. Different strain combinations were 
used with all recipient rats being Lewis and donor rats 
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Fig. 1. Longitudinal section through the leaflet and myocardial cuff of a fresh syngeneic rat aortic valve 
graft at 2 days. Beginning myocellular necrosis and mild infiltration with polymorphonuclear neutrophils 
(arrow) is noted. (Original magnification × 100.) 
Table I. Number of rats in each experimental group 
at each time point 
Days after transplant 
Group 2 7 28 56 
Fresh syngeneic 1 1 8 8 
Fresh allogeneic 3 3 8 8 
Cryopreserved syngeneic - -  - -  - -  8 
Cryopreserved allogeneic - -  - -  - -  8 
being either Lewis (syngeneic) or Brown Norway (alloge- 
neic). Grafts were transplanted either fresh or cryopre- 
served, so that there were four experimental groups: fresh 
syngeneic, fresh allogeneic, cryopreserved syngeneic, and 
cryopreserved allogeneic. All animals were housed and 
fed ad libitum at the Dalhousie University Animal Care 
Center in accordance with the guidelines of the Canadian 
Council of Animal Care. 19 
Surgical technique. Aortic valve transplants were per- 
formed as described by Yankah, Wottge, and Muller- 
Ruchholtz. a3 An intraperitoneal injection of sodium pen- 
tobarbital, 65 mg/kg, was used to anesthetize the rats. 
None of the animals received antibiotics or heparin at any 
time. 
Donor operation. The donor aortic valve was removed 
with a cuff of ventricular muscle and the ascending aorta. 
The coronary arteries were tied with a 10-0 nylon suture 
(Ethilon, Ethicon Inc., Somerville, N.J.). One cusp of the 
valve was sutured to the aortic wall to render the valve 
incompetent and prevent thrombosis. Any excess myocar- 
dial muscle was removed from the valve. The donor graft 
was then placed in cold isotonic saline solution before 
Table II. Preserved leaflets een at different ime 
points 
Group 28 days 56 days 
Fresh syngeneic 7/7 3/5 
Fresh allogeneic 8/8 0/6* 
Cryopreserved syngeneie 2/5 
Cryopreserved allogeneic 0/6? 
Data shown are grafts with preserved leaflets/total successful grafts. 
*Leaflet ghosts were seen in five of six grafts. 
?Leaftet ghosts were seen in all six grafts. 
transplantation for the fresh experiments or cryopre- 
served as described. Both the donor and recipient opera- 
tions were performed with a Weck OM-1206 operating 
microscope (Pilling Weck, Research Triangle Park, N.C.) 
under 7× to 10× magnifications. 
Recipient operation. The abdominal aorta was mobi- 
lized from the inferior vena cava from the level of the left 
renal artery almost down to the aortic bifurcation and 
divided between two vessel clamps. The aortic valve 
allograft was then interposed between the stumps of the 
recipient aorta with a continuous 10-0 nylon suture. 
Cryopreservation. Valves were used immediately after 
harvesting (fresh) or after 2 to 8 weeks of cryopreserva- 
tion. Cryopreservation was performed with the use of 
standard clinical protocols. The explanted aortic valve 
allografts were incubated in Hanks balanced salt solution 
containing gentamicin (80 mg/L) and cefazolin (1 gm/L) 
and stored at 4°C for 24 hours. The valves were then 
removed from this solution, cryopreserved in Hanks bal- 
anced salt solution with 10% dimethylsulfoxide, and pack- 
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Fig. 2. Fresh syngeneic graft at 7 days showing massive infiltration of polymorphonuclear neutrophils in 
media (arrow) and adventitia. (Original magnification × 100.) 
Table II I .  Schematic representation f the histologic appearance of the aortic valve allografi at different ime 
points 
Grafts Intimal thickening Media necrosis Perivascular inflammation Preserved leaflets 
FS 2 days 0 0 0---~+ Yes 
FA 2 days 0 0 0---~+ Yes 
FS 7 days 0 +-+++ ++ Yes 
FA 7 days 0 +--~+ + ++ Yes 
FS 28 days 0--++, focal 0 0 Yes 
FA 28 days +---~+  +--++ + +++ Yes 
FS 56 days +---~+  0-++ +, focal 0 Yes 
FA 56 days + +--++ + + + + + + + No, leaflet ghosts 
CS 56 days + + + + + 0 Yes 
CA 56 days + +--++ + + + + + + No, leaflet ghosts 
F, Fresh; C, cryopreserved; S, syngeneic; A, allogeneic; 0, none; +, mild; + +, moderate; ++ +, severe. 
aged separately in pouches (Kenpak Convertors Incorpo- 
rated, City of Commerce, Calif., and Kapak Corporation, 
St. Louis Park, Minn.). The packaged aortic valves were 
placed in the precooled freezer chamber of a programma- 
ble controlled-rate freezer (Planer KRYO 10, Diamed 
Laboratory Supplies, Mississauga, Ontario, Canada) and 
cooled at a controlled rate of -1 ° C/min to -5 ° C/min to a 
temperature o f -80  ° C, and then labeled and stored at 
below -135° C (Revco Ultralow Freezer, Rheem Manu- 
facturing Company, Asheville, N.C.). For transplantation 
the packaged cryopreserved valve was thawed in a water 
bath at 37 ° C for 10 minutes, removed from the package, 
and implanted. 
Experimental groups. The animals were put to death 
for explantation and histologic examination of the grafts 
at different time points after transplantation according to 
Table I. These times were chosen on the basis of previous 
experience in mouse and rat aortic allografts in which 
we 2° have shown that chronic rejection is evident by 28 
days after transplantation a d well established by 56 days. 
Surgical failures include death of the animal before the 
time of planned eath, obliteration of the graft at explan- 
tation, and aneurysms atthe anastomotic site of the graft. 
These were excluded from analysis. 
Histology. The grafts were explanted with a short seg- 
ment of adjacent recipient aorta and immediately fixed in 
10% buffered formalin solution for at least 24 hours. With 
the use of a syringe and a No. 25 plastic cannula, 10% 
buffered formalin was gently injected into both ends of the 
explanted aortic graft to remove any air and ensure proper 
fixation. The leaflet area was marked with India ink on the 
outside of the graft. The grafts were then embedded in 
paraffin and completely sectioned through with 4/xm thick 
sections and stained with hematoxylin-eosin. We used 
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Fig. 3. A, Horizontal cross section of a fresh syngeneic graft at 28 days showing preserved normal leaflets 
(arrow). (Original magnification ×20.) B, Fresh syngeneic graft at 28 days showing normal structure of 
preserved leaflet, normal media, and adventitia with mild, focal intimal thickening (arrow). (Original 
magnification × 100.) 
longitudinal sections for the 2- and 7-day grafts and 
horizontal sections for the 28- and 56-day grafts. 
Analysis. Histopathologic examination was performed 
by two pathologists blinded to the original protocol and 
study design. All layers of the aortic valve transplants were 
systematically examined. 
Results 
Surgical results. Of 56 animals subjected to 
transplantation, 54 survived the planned time period 
until they were put to death. When the animals were 
put to death, 45 grafts were patent and acceptable 
for histopathologic assessment, six grafts were oblit- 
erated, and three had aneurysms. No differences 
were seen in complications by comparison of cryo- 
preserved grafts with fresh grafts. 
ttistologic results. Tables II and III summarize 
the histopathologic findings of the rat aortic valve 
allografts at the examined time points. 
Fresh syngeneic grafts. At 2 days in the fresh 
syngeneic aortic valve grafts (Fig. 1) the myocardial 
cuff showed evidence of beginning myocellular ne- 
crosis. There was a mild infiltration of the myocar- 
dial cuff and adventitia with polymorphonuclear 
neutrophils (PMNs). The media looked normal. No 
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Fig. 4. A, Horizontal cross section of a fresh syngeneic graft at 56 days with preserved leaflets (arrow). 
(Original magnification ×20.) B, Fresh syngeneic graft at 56 days showing normal structure of leaflet, 
media, and adventitia, but progressive intimal thickening (arrow). (Original magnification × 100.) 
intima was present. The leaflet was preserved but lost 
its endothelium. At 7 days (Fig. 2) there was an 
extensive necrosis of the myocardial cuff. Concomi- 
tantly, a massive infiltration of PMNs and macro- 
phages throughout the myocardial cuff, adventitia, nd 
media was present. The intima was lost completely and 
PMNs were adherent to the lumen. At 28 days in the 
fresh syngeneic grafts (Fig. 3, A and B) sections at the 
valvular level and at the more distal aortic level show 
the adventitia, media, and leaflet o be normal. Focal 
intimal thickening was present. The endothelium was 
generally present on the intima and leaflet. No retro- 
valvular thrombus was seen. At 56 days the fresh 
syngeneic grafts (Fig. 4,A andB) continued to show no 
changes in the adventitia. There were focal areas of 
medial cell loss of varying degrees, but the elastin 
layers were continuous. There was diffuse, but concen- 
tric intimal thickening, which was more prominent 
than at 4 weeks. The leaflets were thin and appeared 
viable and without significant changes. Both the leaflet 
and the neointimal proliferation were still covered 
with endothelium. 
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Fig. 5. Longitudinal section through the l aflet and myocardial cuff of a flesh allogeneic rat aortic valve 
graft at 2 days. Histopathology is similar to syngeneic counterpart. Again, beginning myocellular necrosis 
and mild infiltration with polymorphonuclear neutrophils (arrow) is noted. (Original magnification × 100.) 
Fig. 6. Fresh allogeneic graft at 7 days showing preserved leaflet. Inflammatory cell infiltration of media 
and adventitia (arrow) is seen. (Original magnification ×100.) 
Fresh allogeneic grafts. At 2 and 7 days in the 
fresh allogeneic aortic valve grafts the histopatho- 
logic characteristics do not differ significantly from 
those of the syngeneic graft (Figs. 5 and 6). At 28 
days in the fresh allograft sections at the valvular 
level (Fig. 7, A and B) showed the adventitia to be 
densely infiltrated with mainly lymphocytes and 
macrophages. Areas of prominent vascularity in the 
adventitia were identified. Medial necrosis was vari- 
able but in many places full thickness. There was 
limited presence of inflammatory cells within the 
wall itself. The arrangement of spindle cells and 
elastic fibers appeared normal in the unaffected 
media. The changes in the media were far less 
prominent in the aortic conduit than in the aortic 
root. The aortic lumen showed retrovalvular throm- 
bus development, with early organization of the 
thrombus in many cases. Luminal narrowing had 
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Fig. 7. A, Fresh allogeneic graft at 28 days howing preserved, but dysplastic leaflet (arrow). (Original 
magnification ×20.) B, Section through the dysplastic leaflet and sinus of Valsalva of a fresh allogeneic 
graft at 28 days howing retrovalvular thrombus development (arrow). (Original magnification × 100.) 
occurred. Focal areas of mild to moderate intimal 
thickening were present, consisting mainly of non- 
inflammatory cells and covering the leaflets on the 
luminal side. As yet there were limited changes to 
the leaflet itself other than edema, considerable, 
often complete loss of vitality of valvular stromal 
cells, and loss of the lining endothelium. At 56 days 
in the fresh allogeneic transplants (Fig. 8, A and B) 
the dense lymphocytic cell infiltrate in the adventitia 
remained. There was almost complete and diffuse 
medial necrosis. Free valve leaflets were not pres- 
ent. The aortic lumen showed complete retrovalvu- 
lar thrombosis. The thrombus was now organized, 
and hemosiderin deposits and leaflet ghosts were 
seen within. Significant neointimal proliferation 
with luminal narrowing was seen between the leaflet 
ghosts and the lumen. Distally in the aortic conduit 
the intima was still moderately to markedly thick- 
ened, consisting of mainly spindle cells and a few 
inflammatory cells. 
Cryopreserved syngeneic grafts. At 56days cryopre- 
served syngeneic grafts (Fig.9, A and B) showed an 
unremarkable adventitia. The media showed more 
extensive areas of medial necrosis than in the fresh 
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Fig. 8. A, In the fresh allogeneic graft at 56 days no preserved leaflets areseen. Marked concentric intimal 
thickening is present (arrow) with luminal narrowing. (Original magnification ×20.) B, Fresh allogeneic 
graft at 56 days showing leaflet ghost (small arrow) with neointimal proliferation toward the lumen (open 
arrow) and complete medial necrosis (large arrow). Lymphocytic infiltration f the adventitia persists. 
(Original magnification xl00.) 
syngenelc grafts at 56 days, and only focal areas of 
normal media were present. There was moderate and 
diffuse neointimal proliferation. Preserved leaflets 
were present. Both the leaflet and the neointimal 
proliferation were covered with endothelium. No ret- 
rovalvular thrombus was seen. In the aortic conduit 
neointimal proliferation was rather eccentric. 
Cryopreserved aUogeneic grafts. At 56 days cryo~ 
preserved allogeneic grafts (Fig. 10, A and B) 
showed a moderate to severe mononuclear cell 
infiltrate in the adventitia, consisting mainly of 
lymphocytes and macrophages. There was complete 
and diffuse medial necrosis. Free valve leaflets were 
not present but leaflet ghosts were identified in all 
grafts. The aortic lumen showed complete retroval- 
vular thrombosis. As in the 56-day fresh allogeneic 
grafts, the thrombus was organized with hemosid- 
erin deposits. Between the leaflet ghosts and the 
lumen there was significant neointimal proliferation 
with luminal narrowing. In the aortic conduit here 
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Fig. 9. A, Cryopreserved syngeneic graft at 56 days showing preserved leaflet (arrow) and diffuse 
concentric intimal thickening. (Original magnification ×20.) B, Cryopreserved syngeneic graft at 56 days 
showing loss of cellularity in the media (arrow). (Original magnification × 100.) 
still was neointimal proliferation but less prominent 
and eccentric. Endothelium was seen occasionally. 
Discussion 
Homograft valves are commonly used in cardiac 
surgery, often in children and young adults. Unfor- 
tunately, they are prone to fail and require replace- 
ment, particularly in children. 6-s' 12 The precise 
cause of this failure is unknown, but one main area 
of research as been into the possible immunoge- 
nicity of these homografts. It has been shown that 
recipients of homovital, noncryopreserved ho- 
mografts produce donor HLA-specific antibodies of 
the immunoglobulin G class and that recipients 
of cryopreserved homografts form immunoglobulin 
G-and T cell-mediated reactions to donor HLA 
antigens.9, 11 However, it is unknown whether this 
alloreactivity ultimately results in the observed his- 
topathologic hanges that lead to valve allograft 
failure. This study demonstrates that aortic valve 
allografts in the rat model fail through retrovalvular 
thrombosis and neointimal proliferation. In addi- 
tion, widespread medial necrosis and a lymphocytic 
adventitial infiltration are present in the allografts 
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Fig. 10. A, In the cryopreserved allogeneic graft at 56 days no preserved leaflets areseen. As in the fresh 
allogeneic grafts, marked concentric ntimal thickening is present (arrow) with luminal narrowing. Diffuse 
lymphocytic nfiltration of the adventitia persists (open arrow). (Original magnification ×20.) B, Cryopre- 
served allogeneic graft at 56 days showing leaflet ghost (small arrow) with marked neointimal proliferation 
toward the lumen (open arrow) and complete medial necrosis (large arrow). Hemosiderin is seen in the 
organized retrovalvular thrombus. (Original magnification × 100.) 
but not in the syngeneic grafts. These findings are 
characteristic of acute and chronic rejection and 
have been described in the rat aortic allograft 
model,17, is which does not include the aortic valve. 
Retrovalvular thrombosis in the allograft could 
therefore represent one additional expression of 
alloreactivity. Potential effector mechanisms include 
secretion of cytokines, growth factors, and other 
factors by lymphocytes, endothelial cells, and 
smooth muscle cells, resulting in the up-regulation 
of cell adhesion molecules 17' 18, 21 and leading to 
thrombosis. Already in the early time points there is 
a progressive, massive infiltration of the adventitia 
with PMNs in both the syngeneic and allogeneic 
grafts. This nonspecific inflammatory reaction is at 
least partly caused by the concomitantly trans- 
planted myocardial cuff, which undergoes ischemic 
necrosis. We postulate that this PMN invasion then 
spills over to the media, resulting in medial cell loss 
again in both the syngeneic and allogeneic grafts, 
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which could be the source of release of cytokines, 
growth factors, and other factors. This results in 
intimal thickening in the syngeneic transplants, 
which was observed beginning at 28 days and pro- 
gressing at 56 days. At each time point allogeneic 
grafts demonstrate more extensive neointimal pro- 
liferation than their syngeneic ontrols, as intimal 
thickening in the allogeneic transplants i a result of 
both nonspecific inflammatory response to the ne- 
crotic muscle cuff and ongoing allostimulus of the 
graft itself. The importance of the transplanted 
myocardial cuff has been referred to earlier. 15 By 28 
days the fresh syngeneic graft has regenerated its 
media, and one would expect hat eventually intimal 
thickening in the syngeneic grafts should regress 
once the media is restored. 2° However, we did not 
look at this beyond 56 days. In the allogeneic grafts 
the allostimulus persists and therefore the media 
does not regenerate but continues to mount an 
immune-mediated response, resulting in further me- 
dial necrosis and thus further intimal thickening. 
Syngeneic grafts are expected to not generate an 
immune response and survive indefinitely. 17' 1s, 2o, 22 
The fact that we observed intimal thickening in our 
fresh and cryopreserved syngeneic grafts at 56 days 
leads us to believe that the ultimate histopathologic 
structure of this group of grafts has not yet been 
reached. Intimal thickening in syngeneic grafts has 
been briefly mentioned in the literature without an 
attempt at explanation. 22
Beyond the first 7 days, which were characterized by
a nonspecific inflammatory response, and throughout 
all further time periods a chronic lymphocytic nfiltrate 
persists in the adventitia of the allogeneic grafts. This 
has been described by others 15' 17, 18 and could be 
another source of ongoing production of cytokines and 
other growth factors responsible for smooth muscle 
cell destruction, migration, or transformation, result- 
ing in medial necrosis and neointimal proliferation. 
Leaflet viability may be important for long-term 
allograft valve function. In this study the leaflets 
of fresh syngeneic grafts retained normal struc- 
ture and cellularity for up to 56 days. Fresh 
allogeneic leaflets were dysplastic at 28 days and 
demonstrated an obliterative thrombosis in the 
sinus of Valsalva at 56 days. Cryopreservation did 
not alter the leaflet structure of syngeneic grafts 
nor did it prevent retrovalvular leaflet thrombosis 
in allogeneic grafts. However, cryopreserved syn- 
geneic grafts showed more extensive medial ne- 
crosis than their fresh counterparts, which could 
be partly due to some cytotoxic effect of cryo- 
preservation. 
A criticism of this study is that it is a nonworking 
valve model, which may explain the thrombosis of 
the valves that was seen in the rats and is not seen in 
human beings. Nevertheless, the preservation of 
valve leaflets exclusively in the syngeneic rats is 
strong evidence of immune-mediated damage oc- 
curring only in the allogeneic grafts. We postulate 
that this thrombosis i a marker for such damage. In 
human allografts this injury may lead to loss of 
viability, which will ultimately cause the valve to fail. 
This study demonstrates that aortic valve allo- 
grafts in the rat model undergo histopathologic 
changes that are characteristic of both acute and 
chronic rejection. This rejection process ultimately 
leads to allograft valve failure via a progressive 
obliterative retrovalvular thrombosis that is destruc- 
tive to the valve leaflets. Further studies are needed 
to determine whether similar events might be occur- 
ring in homografts and which mediators are in- 
volved. On the basis of these and other results, 
investigations into therapies to modify this response 
appear justified. This could be achieved either by 
tissue typing and matching donor and recipient or by 
subjecting the recipient o immune suppression for 
an unknown time period. 
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Discussion 
Dr. Charles A. Yankah (Berlin, Germany). I would like 
you to differentiate between cellular and humoral rejec- 
tion. The homograft conduit with myocardium around the 
root, depending on the cellular viability, might undergo 
cell-mediated rejection, as you said, or you will observe a
humoral rejection with production of anti-endothelial ce l 
antibodies. If you implant an acellular or nonviable allo- 
graft without any myocardial tissue, you might have a 
humoral type of rejection, which might be an ongoing 
process or a chronic process. Could you differentiate his 
type of rejection process in your study? 
Dr. Moustapha. We tried to trim the myocardium as 
much as possible. With aortic grafts, that is very difficult 
because of the insertion of the leaflet. We were not able to 
transplant grafts without myocardium, sowe were not able 
to differentiate hat. We always had a minimal myocardial 
rim there. 
Mr. Magdi Yacoub (London, England). My question is 
twofold. First, where did you put the grafts exactly? Were 
these anastomosed in the descending aorta? Do you think 
that site has something to do with it? If you had them in 
the subcoronary position, would that be different? 
Second, which cells in the graft play a role in this 
process of rejection, particularly with regard to antigen 
presentation? Do you think that dendritic ells and/or 
endothelial cells are important, and what is the role of 
myofibroblasts? We have some preliminary data. We have 
early data to suggest important interaction between these 
cells. I would like to know your views. 
Dr. Moustapha. With respect o your first question, 
these were heterotopic transplants into the abdominal 
aorta right underneath the renal vein and above the 
bifurcation. 
With respect o your second question, which cell is 
important? What we saw were basically clinical signs of 
both acute and chronic rejection. I think that in the acute 
rejection phase, the lymphocytic infiltrate is the main 
thing. The lymphocytes, I think, are the dominating factor 
here. 
With respect to the element hat we saw with the 
chronic rejection, I think that it is mostly a combination of
all of the elements hat you mentioned. We saw that in the 
endothelium and the syngeneic grafts. In the allogeneic 
grafts, the endothelium was gone, so I think that plays a 
lesser ole. But the myofibroblasts and the lymphocytes I 
speculate are the ones that are causing the chronic 
damage. 
